6-49606923-T-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000324.3(RHAG):c.1139-2A>G variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,454,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000324.3 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHAG | NM_000324.3 | c.1139-2A>G | splice_acceptor_variant | ENST00000371175.10 | NP_000315.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHAG | ENST00000371175.10 | c.1139-2A>G | splice_acceptor_variant | 1 | NM_000324.3 | ENSP00000360217 | P2 | |||
RHAG | ENST00000646272.1 | c.1139-2A>G | splice_acceptor_variant | ENSP00000494337 | A2 | |||||
RHAG | ENST00000646939.1 | c.1017-2A>G | splice_acceptor_variant | ENSP00000494709 | ||||||
RHAG | ENST00000646963.1 | c.1138+227A>G | intron_variant | ENSP00000495337 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1454348Hom.: 0 Cov.: 28 AF XY: 0.00000138 AC XY: 1AN XY: 724036
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 09, 2017 | This sequence change affects an acceptor splice site in intron 8 of the RHAG gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with RHAG-related disease. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RHAG are known to be pathogenic (PMID: 9759472, 28470789). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.